Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

Luvo Health Tirzepatide Review: Cost, a Real Refund Clawback & Honest Verdict (2026)

An honest 2026 review of Luvo Health tirzepatide — a fully published price list, both brand and compounded options, and a bundle-refund clawback.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

Telos Rx

Compounded injectable, oral, and microdosed tirzepatide from a LegitScript-certified telehealth, with a low annual entry price.

From $139/mo (plan-length dependent)

Check Telos Rx availability

Luvo Health: $339/month for tirzepatide, with a genuinely verified LegitScript seal and a full price list published openly by medication and commitment length — no intake required to view it. Every fact here comes from the company's own published program.

What Luvo Health is

Luvo Health (LUVO HEALTH, INC.) is a multi-program telehealth brand, offering both compounded and brand-name Ozempic and Zepbound in one place. LegitScript certification verified against the issued seal, not just the badge — a genuinely stronger verification than most competitors offer.

§ Luvo Health — Billing and Refund Terms Worth Reading

ItemDetail
Tirzepatide$339/mo
Billing cycle4 weeks (13 charges/year)
Bundle refundRecalculated at non-bundled rate
Verified: $339/mo, LegitScript seal verified. 4-week billing (13 charges/year), bundle refunds clawed back.

What Luvo Health costs

$339/month for tirzepatide. Billing runs per 4-week period, not per calendar month — 13 charges a year rather than 12, a pattern this site has flagged on other providers.

A real refund clawback worth knowing about

This is the most important thing to understand about Luvo Health's terms: you're charged for the first billing period as soon as you submit the intake form, before a clinician has reviewed you. Refunds stop once medication is ordered — for new patients with no video visit, that happens at intake submission. And if you took a multi-month bundle discount, any refund is recalculated at the standard non-bundled rate, clawing back the discount you were given.

The brand-vs-compounded question

Luvo Health offers both compounded tirzepatide and brand-name options (Ozempic, Zepbound) — a real dual pathway, plus oral semaglutide tablets alongside injections. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; the brand option is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

Luvo Health's real strengths: a genuinely verified LegitScript seal, a fully published price list by medication and commitment length with no intake required, both compounded and brand-name options, oral semaglutide tablets, and a full refund if disqualified before medication is ordered. The trade-offs are significant and worth reading closely: billed per 4 weeks, not per month (13 charges a year), charged at intake submission before clinician review for new patients, refunds stop once medication is ordered, 72 hours' notice required for cancellation before the next billing date, and bundle discounts are clawed back if you refund before completing the full term. As with any GLP-1 program, and especially one with this specific billing and refund structure, read the cancellation terms closely before submitting your intake; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

Luvo Health's genuinely verified LegitScript seal and fully published price list are real transparency strengths, confirmed directly, and the dual brand-and-compounded pathway is a genuine option. Read the billing and refund terms closely though — you're charged at intake submission, not after approval, and bundle discounts get clawed back on early refunds. For a provider with simpler calendar-month billing and no clawback clause, compare it against CoreAge Rx or Harper Meds. For a provider whose core business is actually addiction recovery, with GLP-1s offered alongside it, see Recovery Delivered. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through Luvo Health?

$339/month — billed per 4-week period rather than calendar month.

When am I charged with Luvo Health?

At intake submission for new patients without a video visit — before a clinician has actually reviewed you.

Does Luvo Health offer brand-name tirzepatide?

Yes — both compounded and brand-name Ozempic and Zepbound are offered in one place.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.

Related monograph sections

View all sections